17-18 MAY 2019

New Avenues in Brachytherapy


  • 07:30 - 08:00

    Breakfast

    Breakfast and registration

  • 08:00 - 08:10

    Welcome Talk

    Welcome to our 2019 edition of Curietherapies Workshop

     

    Evaluate this activity

  • 08:09 - 10:49

    Session I: Prostate Cancer

    Session I: Prostate Cancer
    Moderators: Tamim Niazi, MD

    Discuss current standards and future innovations in prostate cancer brachytherapy

    Each Talk include a 5 mn question period

  • 08:10 - 08:30

    The Rise of HDR Brachytherapy for Prostate Cancer

    Session I: Prostate Cancer

    Explain the history of brachytherapy for prostate cancer

    Review the LDR brachytherapy era

    Describe the beginnings of HDR brachytherapy

    Explain the characteristics and the differences between HDR and LDR brachytherapy

    Enumerate HDR brachytherapy indications

    Describe the statistics of the increased use of HDR brachytherapy

     

    Evaluate

  • 08:30 - 08:50

    Increased Use of MRI for Patient Selection

    Session I: Prostate Cancer

    Describe the advantages of MRI over CT-scan

    Explain the use of MRI for the selection of patients for active surveillance

    Identify the nodule and boost the DIL 

     

    Evaluate

  • 08:50 - 09:20

    Use of PSMA PET-CT for Patient Selection

    Session I: Prostate Cancer

    Explain the science behind PSMA PET

    Estimate the sensitivity and specificity of this exam

    Define the optimal patient for PSMA PET

    Use the PSMA PET to find the nodule and target the DIL 

     

    Evaluate

  • 09:20 - 09:40

    Predictive Value of Gene Expression in Localized Prostate cancer

    Session I: Prostate Cancer
    Speakers: Dan Lin, MD

    Identify the biomarkers for prostate cancer

    Analyze the Predictive value of biomarkers

    Explain Cell cycle progression markers targeted by radiotherapy

    Explain how a genomic test may help in making a better treatment decision

    Use gene expression markers for reclassification of intermediate risk prostate cancer

     

    Evaluate

  • 09:40 - 10:00

    HDR Brachytherapy Monotherapy: Are we There Yet?

    Session I: Prostate Cancer

    Review the literature

    Explain the toxicities and compare them to LDR toxicities

    Compare toxicities to EBRT or EBRT combined with brachytherapy

    Estimate Disease control

     

    Evaluate

  • 10:00 - 10:20

    Coffee Break

    Coffee break

  • 10:20 - 10:40

    Androgen Deprivation Combined with HDR Brachytherapy: When, Why, and How?

    Session I: Prostate Cancer

    Review the literature supporting androgen deprivation therapy in combination with brachytherapy

    Explain its use in prostate volume reduction

    Discuss the toxicities of this treatment

     

    Evaluate

  • 10:40 - 10:50

    Using Hydrogel Spacers for Prostate Brachytherapy

    Session I: Prostate Cancer

    Describe how to apply the Hydrogel spacers

    Provide its indication and benefits

    Explain rectal toxicity in HDR brachytherapy

     

    Evaluate

     

  • 10:49 - 12:25

    Session II: Skin Cancer

    Session II: Skin Cancer
    Moderators: Boris Bahoric, MD

    Discuss brachytherapy in cutaneous tumors

    Question period at the end of the session

  • 10:50 - 11:10

    Where Does Skin Brachytherapy Stand in 2019

    Session II: Skin Cancer

    Evaluate the role of brachytherapy for skin cancer

    Enumerate the different techniques that can be used

     

    Evaluate

     

  • 11:10 - 11:30

    Clinical Aspects of Contact Therapy with Applicators

    Session II: Skin Cancer

    Describe the different applicators

    Describe the dosimetry, advantages, and disadvantages of each applicator

    Evaluate dose prescription

     

    Evaluate

  • 11:30 - 11:40

    Plesiotherapy: 3D Printers

    Session II: Skin Cancer

    Describe indications of 3-D printers for brachytherapy

    Explain the technical aspects

    Enumerate the steps to create an adequate applicator

     

    Evaluate

  • 11:40 - 12:00

    Peri-operative HDR Brachytherapy for Keloid Scars

    Session II: Skin Cancer

    Review the literature supporting this management

    Enumerate the indications for this treatment

    Discuss the ideal dose

     

    Evaluate

  • 12:00 - 12:25

    Difficult skin cases

    Session II: Skin Cancer

    Discuss the management of selected difficult cases

    Discussion (duration 20 mn). Quiz 3mn

     

    Evaluate

     

  • 12:25 - 13:50

    Lunch

    Lunch and poster viewing

  • 13:49 - 14:50

    Session III: Lower Digestive Tract Cancers

    Session III: Lower Digestive Tract Cancers
    Moderators: David Donath, MD

    Discuss the use of brachytherapy in rectal and anal cancer

    Each talk include a 5 mn question period

  • 13:50 - 14:10

    HDR Endorectal Brachytherapy

    Session III: Lower Digestive Tract Cancers
    Speakers: Te Vuong, MD

    Enumerate the indications of such a treatment.

    Review the side effects and complications of endorectal brachytherapy.

    Discuss the technique and the steps involved in endorectal brachytherapy.

    Analyse the dose prescription and fractionation of endorectal brachytherapy

     

    Evaluate

     

  • 14:10 - 14:30

    Dose Escalation for Rectal Cancer or Papillon Technique 2.0

    Session III: Lower Digestive Tract Cancers

    Analyse the technique and the steps involved for Papillon Technique.

    Enumerate the indications of such a treatment.

    Analyse the dose prescription and fractionation 

    Explain the results of such a treatment


    Evaluate

  • 14:30 - 14:50

    Dosimetry for Endorectal Brachytherapy

    Session III: Lower Digestive Tract Cancers

    Explain the steps for dosimetry in endorectal brachytherapy and Papillon technique

    Analyse the optimization process.

    Describe the steps for quality assurance.

     

    Evaluate

  • 14:50 - 15:20

    Coffee Break

    TBD...

  • 15:20 - 16:00

    Session IV: Young Investigators

    Abstracts selected for oral presentation

    Each talk includes a 3 mn question period

  • 15:20 - 16:10

    Oral presentations

    Session IVa: Young investigator
    Moderators: & Luis Souhami, MD & Alvaro Martinez, MD & Dany Truchon, Medical Physicist

    15:20  7-24 Urethra-Sparing with Intensity Modulated Brachytherapy for Prostate Cancer
     

    Gabriel Famulari   Mcgill University

    15:30  7-20 MR-Compatible Intensity Modulated Brachytherapy for the Treatment of Locally Advanced Cervical Cancer
     

    Marc Morcos, & Shirin A. Enger  

    Mcgill University

    15:40  7-23 TRUS/MRI-Guided Tumor-Targeted Salvaged HDR brachytherapy for Recurrent Prostate Cancer Early Experience at CHUM
     

    Christian Arias, Guila Delouya, Daniel Taussky, Maroie Barkati, Marie-Claude Beauchemin, Samuel Kadoury, Dominic Béliveau-Nadeau, Yannick Hervieux, Jean-Francois Carrier, Cynthia Ménard.  

    Montreal University

    15:50  7-15 Isodose surface volumes in cervix brachytherapy: dependence on image guided adaptation and applicator
     

    Monica Serban1,2, Christian Kirisits, Karen Nkiwane, Isabelle Dumas, Jamema Swamidas, Astrid de Leeuw, Robert Hudej, Gerry Lowe, Nicole Nesvacil, Richard Pötter, Jacob Lindegaard, Kari Tanderup 

    Mcgill University,   Aarhus University Hospital Denmark,   Medical University of Vienna

  • 16:15 - 17:45

    Mini- Workshops

    Each workshop lasts 45 minutes. Each participant may take up to 2 mini-workshops for a total of 1h30 for this activity. In order to assure and adequate discussion and retroaction there will be a maximum of 12 participants per mini-Worshop. You will have to review and evaluate some cases and the anonymized's images sets prior and during the activity and make a decision. Plenty of time is allowed during the session to discuss sensitive points with the monitors. At the end of the session you should have master the objectives

    Post TURP prostate implant 
    • When is it safe to do brachytherapy?
    • Discuss prebrachytherapy imaging
    • What to be aware of? 
    • Evaluate
    G. Morton, C .Salembier, A. G. Martin  
    Dosimetry for intraoperative brachytherapy and contact therapy 
    • Recognize the different ways in dosimetry
    • Discuss the advantages of volumetric dosimetry
    • Discuss pointers
    • Evaluate
    S. Enger, S. David, S. Devic  
     Skin Applicators   
    • How to use the different applicators
    • Discuss Dosimetry
    • What to be aware of
    • Evaluate
    P. Devlin, T. Williams, T. Derashodian  
     Hand on prostate implant 
    • Discuss the different steps
    • Discuss Number of needles in HDR
    • Evaluate
     A. Martinez, M. Jolicoeur,  

     

  • 18:30 - 20:30

    Dinner

    TBD...

  • 07:45 - 08:00

    Breakfast

    Breakfast and registration

  • 07:59 - 08:40

    Session IV: Teaching Brachytherapy

    Session IV: Teaching Brachytherapy
    Moderators: Thu Van Nguyen, MD

    Discuss innovations in brachytherapy teaching strategies

    Each talk includes a 5 mn question

  • 08:00 - 08:05

    Opening Talk

  • 08:05 - 08:20

    Setting Up a Brachytherapy Teaching Program

    Session IV: Teaching Brachytherapy

    Describe the importance of brachytherapy training 

    Explain the CARO initiative

     

    Evaluate

  • 08:20 - 08:40

    Teaching Prostate Implantation by Simulation

    Session IV: Teaching Brachytherapy

    Review the literature about virtual teaching by simulation in the medical field

    Establish possible pplications in brachytherapy teaching

     

    Evaluate

  • 08:39 - 10:20

    Session V: Technical Innovations

    Session V: Technical Innovations
    Moderators: Dany Truchon, Medical Physicist

    Discuss technical innovations in brachytherapy

    Each talk includes a 5mn question period

  • 08:40 - 09:00

    Pseudo-CT (pCT) Images for Precise Reconstruction of Brachytherapy Catheters

    Session V: Technical Innovations

    Explain the basic principles 

    Identify the advantages in radiation oncology


    Evaluate

  • 09:00 - 09:30

    Intensity Modulated Brachytherapy

    Session V: Technical Innovations

    Explain the basic principles 

    Explain the subtleties of dosimetry for IMBT

    Explain the behavior of Ytterbium

    Identify the advantages of the different isotopes used in HDR brachytherapy


    Evaluate

  • 09:30 - 09:40

    Robotic Needle Insertion or Adaptive MR-Guided HDR Prostate Brachytherapy

    Session V: Technical Innovations

    robotic brachytherapy systems

    needle MR-compatible robotic system

    Task Group AAPM

    Discuss Robot-assisted needles insertion under magnetic resonance imaging (MRI) guidance


    Evaluate

  • 09:40 - 09:50

    3D-TRUS-EMT Image Guided HDR prostate Brachytherapy: System Integration and Validation

    Session V: Technical Innovations

    Discuss real time ultrasound image guidance

    Discuss pointers intraoperative vs postimplant dosimetry

    Accuracy of MRI/ultrasound-guided 

    Discuss deformable versus rigid image fusion 


    Evaluate

  • 09:50 - 10:20

    Targeting Tumors with Alpha Emitters: AlphaDaRT

    Session V: Technical Innovations

    Explain the basic principles 

    Explain the subtleties of dosimetry 

    Explain the behavior of alpha emitters

    Explain the possible clinical applications

     

    Evaluate

  • 10:20 - 10:50

    Coffee Break

    Coffee Break

  • 10:49 - 12:00

    Session VI: Gynaecological Cancers

    Session VI: Gynecological Cancers
    Moderators: Thu Van Nguyen, MD

    Discuss innovations in gynaecological brachytherapy

    Each talk includes a 5mn question period

  • 10:50 - 11:10

    Brachytherapy in Medically Inoperable Endometrial Cancer

    Session VI: Gynecological Cancers

    Review the literature 

    Identify the indications and benefits of brachytherapy in these clinical situations

    Discuss the US Guidelines for Brachytherapy 

    Discuss the results of this treatment


    Evaluate

  • 11:10 - 11:30

    3D Transrecal Ultrasound for Intersitial HDR Brachytherapy

    Session VI: Gynecological Cancers

    Identify indications and advantages of the US guidance

    Master needle placement in interstitial Brachytherapy

    Explain the technique for US guidance

     

    Evaluate

  • 11:30 - 11:50

    MRI for 3-D Image Guided Cervix Brachytherapy

    Identify the indications and advantages of MRI use in this clinical situation

    Review GEC-ESTRO recommendations

    Discuss the progress of the EMBRACE protocol


    Evaluate

  • 11:50 - 12:00

    Organ Preservation: Brachytherapy for Vulvar Cancer

    Session VI: Gynecological Cancers

    Identify the localizations which will benefit the most from organ preservation

    Review the literature 

    Discuss the results of such a treatment

     

    Evaluate

  • 12:00 - 13:10

    Lunch

    TBD...

  • 13:09 - 15:55

    Session VII: Breast Cancer

    Session VII: Breast Cancer
    Moderators: Boris Bahoric, MD

    Discuss current standards and coming innovations in breast brachytherapy

    Question period at the end

  • 13:10 - 13:30

    In Vivo Dosimetry

    Session VII: Breast Cancer

    Recognize the necessity of in vivo dosimetry in a breast implant

    Identify the steps for in vivo dosimetry

    Identify the most useful situations for in vivo dosimetry

     

    Evaluate

  • 13:30 - 13:50

    Electronic Brachytherapy

    Session VII: Breast Cancer

    Explain the basic principles of  electronic brachytherapy

    Explain the subtleties of dosimetry 

    Identify the advantages of electronic brachytherapy


    Evaluate

  • 13:50 - 14:10

    Intra-operative Brachytherapy

    Session VII: Breast Cancer

    Review the literature

    Explain the indications and the results of this treatment

    Identify the toxicities of this treatment

     

    Evaluate

     

  • 14:10 - 14:25

    Interstitial Brachytherapy for partial breast irradiation

    Session VII: Breast Cancer

    Review the literature concerning partial breast irradiation

    Explain the results of this treatment


    Evaluate

  • 14:25 - 14:35

    Interstitial Brachytherapy for Breast Conservation after Recurrence

    Session VII: Breast Cancer

    Explain the subtleties of an adequate treatment

    Discuss this treatment alternative with patients


    Evaluate

  • 14:35 - 14:55

    Breast Brachytherapy with Mobetron

    Session VII: Breast Cancer

    Explain the basic principles of  Mobetron

    Explain the subtleties of dosimetry for Mobetron

    Identify the indications and the advantages of this treatment

    Review the literature results

     

    Evaluate

        

  • 14:55 - 15:55

    Discussion

    Session VII: Breast Cancer
    Moderators: Marjory Jolicoeur, MD

    Discuss controversil topics about brachytherapy

    Question period